464 related articles for article (PubMed ID: 32321820)
1. Impact of HLA-B*52:01-Driven Escape Mutations on Viral Replicative Capacity.
Tsai MC; Singh S; Adland E; Goulder P
J Virol; 2020 Jun; 94(13):. PubMed ID: 32321820
[TBL] [Abstract][Full Text] [Related]
2. Consequences of HLA-B*13-Associated Escape Mutations on HIV-1 Replication and Nef Function.
Shahid A; Olvera A; Anmole G; Kuang XT; Cotton LA; Plana M; Brander C; Brockman MA; Brumme ZL
J Virol; 2015 Nov; 89(22):11557-71. PubMed ID: 26355081
[TBL] [Abstract][Full Text] [Related]
3. Differential escape patterns within the dominant HLA-B*57:03-restricted HIV Gag epitope reflect distinct clade-specific functional constraints.
Payne RP; Branch S; Kløverpris H; Matthews PC; Koofhethile CK; Strong T; Adland E; Leitman E; Frater J; Ndung'u T; Hunter E; Haubrich R; Mothe B; Edwards A; Riddell L; Chen F; Harrigan PR; Brumme ZL; Mallal S; John M; Jooste JP; Shapiro R; Deeks SG; Walker BD; Brander C; Landis C; Carlson JM; Prado JG; Goulder PJ
J Virol; 2014 May; 88(9):4668-78. PubMed ID: 24501417
[TBL] [Abstract][Full Text] [Related]
4. Impact of HLA selection pressure on HIV fitness at a population level in Mexico and Barbados.
Juarez-Molina CI; Payne R; Soto-Nava M; Avila-Rios S; Valenzuela-Ponce H; Adland E; Leitman E; Brener J; Muenchhoff M; Branch S; Landis C; Reyes-Teran G; Goulder P
J Virol; 2014 Sep; 88(18):10392-8. PubMed ID: 25008926
[TBL] [Abstract][Full Text] [Related]
5. Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
Ojwach DBA; MacMillan D; Reddy T; Novitsky V; Brumme ZL; Brockman MA; Ndung'u T; Mann JK
J Virol; 2018 Oct; 92(19):. PubMed ID: 29997209
[TBL] [Abstract][Full Text] [Related]
6. Lack of a significant impact of Gag-Protease-mediated HIV-1 replication capacity on clinical parameters in treatment-naive Japanese individuals.
Sakai K; Chikata T; Brumme ZL; Brumme CJ; Gatanaga H; Oka S; Takiguchi M
Retrovirology; 2015 Nov; 12():98. PubMed ID: 26585907
[TBL] [Abstract][Full Text] [Related]
7. Effects of Mutations on Replicative Fitness and Major Histocompatibility Complex Class I Binding Affinity Are Among the Determinants Underlying Cytotoxic-T-Lymphocyte Escape of HIV-1 Gag Epitopes.
Du Y; Zhang TH; Dai L; Zheng X; Gorin AM; Oishi J; Wu TT; Yoshizawa JM; Li X; Yang OO; Martinez-Maza O; Detels R; Sun R
mBio; 2017 Nov; 8(6):. PubMed ID: 29184023
[TBL] [Abstract][Full Text] [Related]
8. HIV immune escape at an immunodominant epitope in HLA-B*27-positive individuals predicts viral load outcome.
Ammaranond P; van Bockel DJ; Petoumenos K; McMurchie M; Finlayson R; Middleton MG; Davenport MP; Venturi V; Suzuki K; Gelgor L; Kaldor JM; Cooper DA; Kelleher AD
J Immunol; 2011 Jan; 186(1):479-88. PubMed ID: 21115730
[TBL] [Abstract][Full Text] [Related]
9. Rapid HIV disease progression following superinfection in an HLA-B*27:05/B*57:01-positive transmission recipient.
Brener J; Gall A; Hurst J; Batorsky R; Lavandier N; Chen F; Edwards A; Bolton C; Dsouza R; Allen T; Pybus OG; Kellam P; Matthews PC; Goulder PJR
Retrovirology; 2018 Jan; 15(1):7. PubMed ID: 29338738
[TBL] [Abstract][Full Text] [Related]
10. Selection of an HLA-C*03:04-Restricted HIV-1 p24 Gag Sequence Variant Is Associated with Viral Escape from KIR2DL3+ Natural Killer Cells: Data from an Observational Cohort in South Africa.
Hölzemer A; Thobakgale CF; Jimenez Cruz CA; Garcia-Beltran WF; Carlson JM; van Teijlingen NH; Mann JK; Jaggernath M; Kang SG; Körner C; Chung AW; Schafer JL; Evans DT; Alter G; Walker BD; Goulder PJ; Carrington M; Hartmann P; Pertel T; Zhou R; Ndung'u T; Altfeld M
PLoS Med; 2015 Nov; 12(11):e1001900; discussion e1001900. PubMed ID: 26575988
[TBL] [Abstract][Full Text] [Related]
11. Two Distinct Mechanisms Leading to Loss of Virological Control in the Rare Group of Antiretroviral Therapy-Naive, Transiently Aviremic Children Living with HIV.
Vieira VA; Adland E; Grayson NE; Csala A; Richards F; Dacon C; Athavale R; Tsai MH; D'Souza R; Muenchhoff M; Bonsall D; Jooste P; Goulder PJR
J Virol; 2022 Jan; 96(2):e0153521. PubMed ID: 34757843
[TBL] [Abstract][Full Text] [Related]
12. Changes in HIV-1 Capsid Stability Induced by Common Cytotoxic-T-Lymphocyte-Driven Viral Sequence Mutations.
Schommers P; Martrus G; Matschl U; Sirignano M; Lütgehetmann M; Richert L; Hope TJ; Fätkenheuer G; Altfeld M
J Virol; 2016 Aug; 90(16):7579-7586. PubMed ID: 27279617
[TBL] [Abstract][Full Text] [Related]
13. HIV subtype influences HLA-B*07:02-associated HIV disease outcome.
Kløverpris HN; Adland E; Koyanagi M; Stryhn A; Harndahl M; Matthews PC; Shapiro R; Walker BD; Ndung'u T; Brander C; Takiguchi M; Buus S; Goulder P
AIDS Res Hum Retroviruses; 2014 May; 30(5):468-75. PubMed ID: 24010680
[TBL] [Abstract][Full Text] [Related]
14. Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
Brockman MA; Schneidewind A; Lahaie M; Schmidt A; Miura T; Desouza I; Ryvkin F; Derdeyn CA; Allen S; Hunter E; Mulenga J; Goepfert PA; Walker BD; Allen TM
J Virol; 2007 Nov; 81(22):12608-18. PubMed ID: 17728232
[TBL] [Abstract][Full Text] [Related]
15. Differential Immunodominance Hierarchy of CD8
Adland E; Hill M; Lavandier N; Csala A; Edwards A; Chen F; Radkowski M; Kowalska JD; Paraskevis D; Hatzakis A; Valenzuela-Ponce H; Pfafferott K; Williams I; Pellegrino P; Borrow P; Mori M; Rockstroh J; Prado JG; Mothe B; Dalmau J; Martinez-Picado J; Tudor-Williams G; Frater J; Stryhn A; Buus S; Teran GR; Mallal S; John M; Buchbinder S; Kirk G; Martin J; Michael N; Fellay J; Deeks S; Walker B; Avila-Rios S; Cole D; Brander C; Carrington M; Goulder P
J Virol; 2018 Feb; 92(4):. PubMed ID: 29167337
[TBL] [Abstract][Full Text] [Related]
16. Differential narrow focusing of immunodominant human immunodeficiency virus gag-specific cytotoxic T-lymphocyte responses in infected African and caucasoid adults and children.
Goulder PJ; Brander C; Annamalai K; Mngqundaniso N; Govender U; Tang Y; He S; Hartman KE; O'Callaghan CA; Ogg GS; Altfeld MA; Rosenberg ES; Cao H; Kalams SA; Hammond M; Bunce M; Pelton SI; Burchett SA; McIntosh K; Coovadia HM; Walker BD
J Virol; 2000 Jun; 74(12):5679-90. PubMed ID: 10823876
[TBL] [Abstract][Full Text] [Related]
17. Role of Escape Mutant-Specific T Cells in Suppression of HIV-1 Replication and Coevolution with HIV-1.
Zhang Y; Kuse N; Akahoshi T; Chikata T; Gatanaga H; Oka S; Murakoshi H; Takiguchi M
J Virol; 2020 Sep; 94(19):. PubMed ID: 32699092
[TBL] [Abstract][Full Text] [Related]
18. Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.
Serwanga J; Nakiboneka R; Mugaba S; Magambo B; Ndembi N; Gotch F; Kaleebu P
Vaccine; 2015 Mar; 33(14):1664-72. PubMed ID: 25728323
[TBL] [Abstract][Full Text] [Related]
19. Effect of Difference in Consensus Sequence between HIV-1 Subtype A/E and Subtype B Viruses on Elicitation of Gag-Specific CD8
Zhang Y; Murakoshi H; Chikata T; Akahoshi T; Tran GV; Nguyen TV; Gatanaga H; Nguyen KV; Oka S; Kuse N; Takiguchi M
J Virol; 2021 Feb; 95(6):. PubMed ID: 33361435
[TBL] [Abstract][Full Text] [Related]
20. Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
Martinez-Picado J; Prado JG; Fry EE; Pfafferott K; Leslie A; Chetty S; Thobakgale C; Honeyborne I; Crawford H; Matthews P; Pillay T; Rousseau C; Mullins JI; Brander C; Walker BD; Stuart DI; Kiepiela P; Goulder P
J Virol; 2006 Apr; 80(7):3617-23. PubMed ID: 16537629
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
